Gold prices are on track for a weekly decline as rising crude oil prices, driven by U.S.-Iran tensions, amplify fears of persistent inflation. This has led investors to price in a more hawkish Federal Reserve, overshadowing gold's traditional safe-haven appeal.
Gold prices declined on Monday as rising oil prices, spurred by U.S.-Iran military strikes, amplified concerns about persistent inflation and a hawkish Federal Reserve. The precious metal found some support from safe-haven demand but remained under pressure ahead of key U.S. inflation data.
The British pound weakened against the U.S. dollar on Monday as escalating geopolitical risks in the Middle East drove oil prices higher, increasing demand for the greenback as a safe-haven asset.
A plan by corporate bitcoin holder Strategy to authorize up to $1.25 billion in further sales is intensifying scrutiny on the viability of publicly-listed companies that have built their business model on hoarding digital assets amid a market downturn.
Shares of the German airport operator rose after analysts at Exane BNP Paribas upgraded the stock, projecting a significant improvement in cash flow as the company's intensive investment phase nears completion.
Bravida Holding AB reported a 59% increase in second-quarter profit, fueled by 9% organic sales growth and a 44% surge in order intake from major data centre projects.
The AI startup has brought on the prominent UK tech figure and Y Combinator partner to join its compute division, signaling a strategic move amid the industry's intense competition for talent.
AstraZeneca shares fell after HSBC downgraded the stock to 'Hold' from 'Buy,' citing increased execution risk for the company's ambitious $80 billion revenue target following a recent high-profile trial failure.
Shares of Micron and Western Digital fell sharply in premarket trading, dragged down by a selloff in South Korean chipmaker SK Hynix. In contrast, biotech firm Agenus surged after announcing a significant private placement financing deal.
